000 00902 a2200241 4500
005 20250517193005.0
008 ####s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.21136
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLv, Wan-Qi
245 0 0 _aGene editing of the extra domain A positive fibronectin in various tumors, amplified the effects of CRISPR/Cas system on the inhibition of tumor progression.
_h[electronic resource]
260 _bOncotarget
_cDec 2017
300 _a105020-105036 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aWang, Hai-Cheng
700 1 _aPeng, Jing
700 1 _aWang, Yi-Xiang
700 1 _aJiang, Jiu-Hui
700 1 _aLi, Cui-Ying
773 0 _tOncotarget
_gvol. 8
_gno. 62
_gp. 105020-105036
856 4 0 _uhttps://doi.org/10.18632/oncotarget.21136
_zAvailable from publisher's website
999 _c27932389
_d27932389